• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Intermountain Forms Value-Based Care Company

Article

A new comprehensive health platform company will focus on elevating value-based care capabilities with providers, payers, healthcare systems, and ACOs.

Intermountain healthcare logo
Rajesh Shrestha,

Rajesh Shrestha,

Intermountain Healthcare is forming a new value-based care company. 

Called Castell, the company will offer a comprehensive platform of tools and services to support practice transformation and improvement. These resources will help all parts of the health ecosystem promote wellness for patients and excel within a value-based healthcare world.

“Intermountain has actively developed tools and initiatives to help providers and others successfully implement value-based care for years,” says Rajesh Shrestha, president and CEO of Castell. “Castell is one part of that work that we’re excited to officially share now."

Related article: Intermountain Healthcare, deCODE Launch Largest DNA Mapping Project in United States

The new company will offer a comprehensive platform of tools and services to support transformation and improvement:

  • A proven value-based clinical care model called “Reimagined Primary Care”

  • A technology and analytics platform to guide care

  • Streamlined affiliated network management

  • Digital tools to address virtual care, patient experience, and social determinants of health

  • Access to cutting-edge initiatives and innovation coming out of Intermountain Healthcare

  • Opportunity to utilize care pathways and clinical best practices developed by Intermountain Healthcare 

“We continually see that without the right level of support, it is difficult for providers, health systems, payers, and others to thrive in a value-based healthcare world,” Shrestha says. “Intermountain’s day-to-day frontline experience and success in value-based care management programs make us uniquely prepared to extend our services to others through Castell. We are energized by this opportunity to simplify value-based care and help set the direction for the healthcare of the future.” 

Related Videos
Video 2 - "Traditional Treatment of Demodex Blepharitis, FDA approval, and Lotilaner Ophthalmic Solution, 0.25%"
Video 1 - "Demodex Blepharitis: Prevalence, Symptoms, Quality of Life Impact, and Diagnosis"
Video 2 - "The Role of Ruxolitinib in Managing Hydroxyurea Resistance or Intolerance"
Video 1 - "Prevalence and Impact of Hydroxyurea Intolerance or Resistance in Polycythemia Vera"
Video 8 - "Risk and Value-Based Contracting for Prescription Drug Therapeutics and Manufacturer’s Support in Utilization"
Video 7 - "Prescribing Prescription Drug Therapeutics: Factors for Providers and Payers to Consider"
Related Content
© 2024 MJH Life Sciences

All rights reserved.